Short answer
Privia Health Group, Inc. (PRVA) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $633M (up 21.4% year over year) with net income of $9M.
Q2 2026 key financials · XBRL
- Revenue
- $633M
- +21.4% YoY · +4.8% QoQ
- Net income
- $9M
- +236.7% YoY · +195.3% QoQ
- Operating margin
- 1.9%
- EPS (diluted)
- $0.07
- +250.0% YoY · +250.0% QoQ
Source: XBRL data from the Privia Health Group, Inc. (PRVA) Q2 2026 10-Q on SEC EDGAR. USD.
Privia Health Group, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $632.6M, up $111.5M from $521.2M YoY
- Care Margin $132.1M, 20.9% of revenue vs 22.1% YoY
- Platform Contribution Margin 52.2% vs 49.9%; Adjusted EBITDA Margin 28.3% vs 25.2%
- Attributed Lives 1.647M, up from 1.382M; Practice Collections $970.0M vs $862.9M
- Growth investments in services, sales, marketing, technology, and clinical capabilities; payer-renewal risks cited as headwinds
Risk Factors
- No material changes to risk factors disclosed in the prior Annual Report
- No newly added risk factor identified in the quarter
- No materially updated regulatory, legal, compliance, operational, competitive, market, or financial risk disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Privia Health Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.